Carbiotix first US patent for CarbiAXOS has been allowed for issuance
Carbiotix (publ) ("Carbiotix" or "Company") announces today that the first US patent for the production of CarbiAXOS has been allowed for issuance by the US Patent Office. This is an important milestone as the Company prepares for the launch of a CarbiAXOS nutraceutical ingredient in the US during 2022 and in 2023 begins to plan for US production activities.Carbiotix received confirmation from the USPTO, US patent authority, that the Company’s US Patent Application no.15759228, titled: Low Molecular Weight Arabinoxylans with Branched Oligosaccharides, has been allowed for issuance. This is